Spencer Phillips Hey

2.4k total citations · 1 hit paper
68 papers, 1.5k citations indexed

About

Spencer Phillips Hey is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and Statistics and Probability. According to data from OpenAlex, Spencer Phillips Hey has authored 68 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Economics and Econometrics, 26 papers in Public Health, Environmental and Occupational Health and 17 papers in Statistics and Probability. Recurrent topics in Spencer Phillips Hey's work include Health Systems, Economic Evaluations, Quality of Life (30 papers), Ethics in Clinical Research (21 papers) and Statistical Methods in Clinical Trials (16 papers). Spencer Phillips Hey is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (30 papers), Ethics in Clinical Research (21 papers) and Statistical Methods in Clinical Trials (16 papers). Spencer Phillips Hey collaborates with scholars based in United States, Canada and United Kingdom. Spencer Phillips Hey's co-authors include Aaron S. Kesselheim, Bishal Gyawali, Jonathan Kimmelman, Vinay Prasad, Alyson Haslam, Jennifer Gill, Charles Weijer, Valerie H. Taylor, Deborah Christie and Russell Viner and has published in prestigious journals such as Science, PLoS ONE and Neurology.

In The Last Decade

Spencer Phillips Hey

66 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval

2019 194 citations Bishal Gyawali, Spencer Phillips Hey et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Spencer Phillips Hey United States	21	479	282	268	228	213	68	1.5k
Nicholas Latimer United Kingdom	29	855 1.8×	542 1.9×	199 0.7×	510 2.2×	280 1.3×	107	2.7k
Priscilla Velentgas United States	18	188 0.4×	100 0.4×	219 0.8×	275 1.2×	318 1.5×	42	1.8k
Ateesha F. Mohamed United States	23	540 1.1×	105 0.4×	126 0.5×	200 0.9×	194 0.9×	66	1.3k
Amr Makady Netherlands	12	643 1.3×	232 0.8×	122 0.5×	92 0.4×	171 0.8×	27	1.2k
Jenerius A. Aminawung United States	16	526 1.1×	135 0.5×	175 0.7×	161 0.7×	280 1.3×	42	1.4k
Tessa Kennedy‐Martin United States	18	439 0.9×	84 0.3×	156 0.6×	84 0.4×	201 0.9×	28	2.1k
Gregory W. Daniel United States	20	343 0.7×	138 0.5×	132 0.5×	137 0.6×	90 0.4×	46	1.5k
Beate Wieseler Germany	20	489 1.0×	125 0.4×	284 1.1×	60 0.3×	170 0.8×	36	1.5k
Karen E. Bremner Canada	29	649 1.4×	74 0.3×	258 1.0×	483 2.1×	203 1.0×	95	2.2k
Christoph Hürny Switzerland	26	352 0.7×	87 0.3×	290 1.1×	1.1k 4.7×	169 0.8×	67	2.1k

Countries citing papers authored by Spencer Phillips Hey

Since Specialization

Citations

This map shows the geographic impact of Spencer Phillips Hey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spencer Phillips Hey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spencer Phillips Hey more than expected).

Fields of papers citing papers by Spencer Phillips Hey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spencer Phillips Hey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spencer Phillips Hey. The network helps show where Spencer Phillips Hey may publish in the future.

Co-authorship network of co-authors of Spencer Phillips Hey

This figure shows the co-authorship network connecting the top 25 collaborators of Spencer Phillips Hey. A scholar is included among the top collaborators of Spencer Phillips Hey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spencer Phillips Hey. Spencer Phillips Hey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hey, Spencer Phillips, et al.. (2023). Digital Health Technologies in Clinical Trials: An Ontology-Driven Analysis to Inform Digital Sustainability Policies. Therapeutic Innovation & Regulatory Science. 57(6). 1269–1278. 4 indexed citations

McDonald, Ryan, Babak Tofighi, Jennifer McNeely, et al.. (2022). Opioid Use Disorder Treatments: An Evidence Map. Drug and Alcohol Dependence. 241. 109657–109657. 1 indexed citations

Taljaard, Monica, Stuart G. Nicholls, Kelly Carroll, et al.. (2022). An analysis of published trials found that current use of pragmatic trial labels is uninformative. Journal of Clinical Epidemiology. 151. 113–121. 9 indexed citations

Largent, Emily A., Spencer Phillips Hey, Kristin Harkins, et al.. (2020). Ethical and Regulatory Issues for Embedded Pragmatic Trials Involving People Living with Dementia. eYLS (Yale Law School). 1 indexed citations

Gyawali, Bishal, Spencer Phillips Hey, & Aaron S. Kesselheim. (2020). Evaluating the evidence behind the surrogate measures included in the FDA's table of surrogate endpoints as supporting approval of cancer drugs. EClinicalMedicine. 21. 100332–100332. 103 indexed citations

Nicholls, Stuart G., Merrick Zwarenstein, Spencer Phillips Hey, et al.. (2020). The importance of decision intent within descriptions of pragmatic trials. Journal of Clinical Epidemiology. 125. 30–37. 13 indexed citations

Hey, Spencer Phillips, et al.. (2019). Surrogate Endpoints and Drug Regulation: What Is Needed to Clarify the Evidence. The Journal of Law Medicine & Ethics. 47(3). 381–387. 2 indexed citations

Hey, Spencer Phillips. (2019). Why High Drug Pricing Is A Problem for Research Ethics. Journal of Bioethical Inquiry. 17(1). 29–35.

D’Andrea, Elvira, Spencer Phillips Hey, Cherie L. Ramirez, & Aaron S. Kesselheim. (2019). Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes. JAMA Network Open. 2(4). e192224–e192224. 60 indexed citations

10.

Nicholls, Stuart G., Kelly Carroll, Jamie Brehaut, et al.. (2018). Stakeholder views regarding ethical issues in the design and conduct of pragmatic trials: study protocol. BMC Medical Ethics. 19(1). 90–90. 8 indexed citations

11.

Hey, Spencer Phillips. (2017). Ethical Challenges in Biomarker‐Driven Drug Development. Clinical Pharmacology & Therapeutics. 103(1). 23–25. 8 indexed citations

12.

Hey, Spencer Phillips, Jessica M. Franklin, Jerry Avorn, & Aaron S. Kesselheim. (2017). Success, Failure, and Transparency in Biomarker-Based Drug Development. Circulation Cardiovascular Quality and Outcomes. 10(6). 8 indexed citations

13.

Hey, Spencer Phillips, Alex John London, Charles Weijer, Annette Rid, & Franklin G. Miller. (2017). Is the concept of clinical equipoise still relevant to research?. BMJ. 359. j5787–j5787. 27 indexed citations

14.

Hey, Spencer Phillips & Aaron S. Kesselheim. (2016). An Uninformative Truth: The Logic of Amarin’s Off-Label Promotion. PLoS Medicine. 13(3). e1001978–e1001978. 3 indexed citations

15.

Hey, Spencer Phillips & Jonathan Kimmelman. (2015). Are outcome-adaptive allocation trials ethical?. Clinical Trials. 12(2). 102–106. 74 indexed citations

16.

Hey, Spencer Phillips. (2015). Complex Underdetermination and the Units of Clinical Translation. THEORIA An International Journal for Theory History and Foundations of Science. 30(2). 207–207. 3 indexed citations

17.

Carlisle, Benjamin Gregory, Nathalie MacKinnon, Tim Ramsay, et al.. (2015). Benefit, Risk, and Outcomes in Drug Development: A Systematic Review of Sunitinib. JNCI Journal of the National Cancer Institute. 108(1). 45 indexed citations

18.

Hey, Spencer Phillips. (2014). Robust and Discordant Evidence: Methodological Lessons from Clinical Research. Philosophy of Science. 82(1). 55–75. 10 indexed citations

19.

Hey, Spencer Phillips. (2014). Theory Testing and Implication in Clinical Trials. PhilSci-Archive (University of Pittsburgh). 1 indexed citations

20.

Viner, Russell, Deborah Christie, Valerie H. Taylor, & Spencer Phillips Hey. (2003). Motivational/solution‐focused intervention improves HbA_1c in adolescents with Type 1 diabetes: a pilot study. Diabetic Medicine. 20(9). 739–742. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact